Christopher Bowden
2020
Compensation breakdown
| Non-Equity Incentive Plan | $243,341 |
|---|---|
| Option Awards | $1,508,875 |
| Salary | $515,007 |
| Stock Awards | $618,120 |
| Other | $9,203 |
| Total | $2,894,546 |
Bowden received $1.5M in option awards, accounting for 52% of the total pay in 2020.
Bowden also received $243.3K in non-equity incentive plan, $515K in salary, $618.1K in stock awards and $9.2K in other compensation.
Rankings
In 2020, Christopher Bowden's compensation ranked 4,002nd out of 13,090 executives tracked by ExecPay. In other words, Bowden earned more than 69.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,002 out of 13,090 | 69th |
Division Manufacturing | 1,612 out of 5,621 | 71st |
Major group Chemicals And Allied Products | 613 out of 2,254 | 73rd |
Industry group Drugs | 529 out of 1,954 | 73rd |
Industry Pharmaceutical Preparations | 403 out of 1,459 | 72nd |
Pay ratio
| Christopher Bowden's Pay | $2,894,546 |
|---|---|
| Median Employee's Pay | $253,211 |
| Pay Ratio | 11to 1 |
In 2020, the annual total compensation of Christopher Bowden was $2,894,546.
The annual total compensation of the median employee at Agios Pharmaceuticals was $253,211.
The ratio of Christopher Bowden's pay to the pay of median employee was therefore 11 to one.
Bowden's colleagues
We found four more compensation records of executives who worked with Christopher Bowden at Agios Pharmaceuticals in 2020.
News
April 28, 2022
April 8, 2021
April 16, 2020
April 18, 2019